Benchmark downgraded shares of Select Medical (NYSE:SEM – Free Report) from a buy rating to a hold rating in a report released on Monday, Marketbeat reports.
A number of other analysts have also recently weighed in on SEM. StockNews.com cut shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Thursday, November 21st. Royal Bank of Canada lifted their target price on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Finally, Bank of America assumed coverage on shares of Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price objective for the company. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Select Medical currently has an average rating of “Hold” and a consensus target price of $40.75.
Check Out Our Latest Stock Report on SEM
Select Medical Price Performance
Select Medical (NYSE:SEM – Get Free Report) last issued its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter last year, the business posted $0.46 EPS. The company’s revenue was up 5.7% compared to the same quarter last year. On average, equities research analysts predict that Select Medical will post 2.16 EPS for the current fiscal year.
Select Medical Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were paid a dividend of $0.125 per share. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a yield of 2.46%. Select Medical’s dividend payout ratio (DPR) is presently 23.36%.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. Vanguard Group Inc. lifted its position in Select Medical by 5.3% in the 1st quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider’s stock valued at $391,886,000 after acquiring an additional 650,093 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Select Medical by 2.2% during the second quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock valued at $157,728,000 after buying an additional 95,578 shares during the last quarter. Geode Capital Management LLC raised its position in Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after buying an additional 46,880 shares during the last quarter. Principal Financial Group Inc. lifted its stake in Select Medical by 6.7% during the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after acquiring an additional 147,032 shares in the last quarter. Finally, Point72 Asset Management L.P. boosted its holdings in Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after acquiring an additional 1,216,263 shares during the last quarter. 89.48% of the stock is owned by institutional investors.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Read More
- Five stocks we like better than Select Medical
- What is Put Option Volume?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is the Nasdaq? Complete Overview with History
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Stock Splits, Do They Really Impact Investors?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.